UF neuroscientist discusses return to the lab for Nature Podcast
In a new podcast, Dr. Malú Tansey discusses how her team helped lead the way in UF’s efforts to bring researchers safely back to the lab.
Posted in
News
The pandemic’s effects on recruiting international STEM trainees
Article in The Scientist featuring Dr. Malú Tansey examines COVID-19's impact on recruiting.
MBI unveils newly renovated labs
Renovations to the MBI’s ground floor provide investigators access to the most up-to-date state-of-the-art facilities.
UF neuroscientist earns Race Against Dementia Fellowship
Dr. Cara Croft awarded prestigious five-year fellowship supporting a collaborative UF-University College London project.
CTRND director featured on Sydney TV news station
Dr. Malú Tansey shared insights into the role of inflammation in dementia following her keynote address at an international conference.
New model to study Alzheimer’s, Parkinson’s may help pinpoint disease mechanisms
In a new study published in the Journal of Experimental Medicine, a team led by Cara Croft, Ph.D., has demonstrated a novel method using viruses and mouse brain slice cultures to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. “We’ve been able to set up…
CTRND Researchers Give Hope for Potential Future Alzheimer’s Disease Treatments
Dr. Todd Golde, Dr. Brenda Moore, and Dr. Diego Rincon-Limas publish a paper in Journal Of Experimental Medicine which gives hope for potential treatments of Alzheimer’s Disease. Read the UF Press Release HERE…
Partnership with Tyler’s Hope for a Dystonia Cure
The CTRND has formed a partnership with the Tyler’s Hope Organization. Dystonia is a neurological movement disorder characterized by involuntary muscle contractions, which force certain parts of the body into abnormal, sometimes painful, movements or postures. Dystonia can affect any part of the body including the…
CTRND Researcher Published in The Journal of Neuroscience
CTRND faculty member Dr. Yona Levites has a paper published in the April 22, 2015 edition of The Journal of Neuroscience. Dr. Levites comments, “A study looking at anti-amyloid properties of a naturally occurring human monoclonal antibody. This is a first time we were able to demonstrate that an antibody cloned from…
CTRND Researcher Named a Fellow by the American Heart Association
Dr. Sylvain Doré has been named a Fellow of the American Heart Association for his research on Stroke. Please join the CTRND in congratulating Dr. Doré for this honor conferred by the Stroke Council of the American Heart Association…